Загрузка...
Novel fluoronucleoside analog NCC inhibits lamivudine-resistant hepatitis B virus in a hepatocyte model
Antiviral drug resistance is the most important factor contributing to treatment failure using nucleos(t)ide analogs such as lamivudine for chronic infection with hepatitis B virus (HBV). Development of a system supporting efficient replication of clinically resistant HBV strains is imperative, and...
Сохранить в:
| Главные авторы: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2018-11-01
|
| Серии: | Brazilian Journal of Infectious Diseases |
| Online-ссылка: | http://www.sciencedirect.com/science/article/pii/S1413867018304975 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|